ClinicalTrials.Veeva

Menu

The Correlation Between Genetic Polymorphism, Platelet Activity, Clopidogrel Responsiveness, and Serum Adipokine Concentration in Asian Acute Coronary Syndrome Patients

C

China Medical University

Status

Unknown

Conditions

Chronic Coronary Artery Disease
Acute Coronary Syndrome

Study type

Observational

Funder types

Other

Identifiers

NCT01255267
DMR99-IRB-041

Details and patient eligibility

About

In this study, we evaluate the acute coronary syndrome patients to see if there is correlation between platelet activity, genetic polymorphism (CYP2C19 and ABCB1), serum adipokines level, and Clopidogrel responsiveness.

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Age > 18 y/o
  2. Acute coronary syndrome patients
  3. Chronic coronary artery disease patients
  4. Healthy volunteers

Exclusion criteria

  1. Patient refusal
  2. Allergy to Clopidogrel
  3. Receive Gp IIb/IIIa inhibitor simultaneously
  4. Cancer history
  5. Severe renal and liver function impairment
  6. Coagulopathy

Trial design

0 participants in 3 patient groups

Acute coronary syndrome patients
Chronic coronary artery disease patients
Healthy control

Trial contacts and locations

1

Loading...

Central trial contact

Yu-Chen Wang, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems